Purchase Order SPE2DP26P0810
Award Date 5/13/26
Potential Completion Date 5/26/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chesapeake, VA 23321, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Medical Supply Chain awarded a purchase order to MR Unlimited, LLC, a service-disabled veteran-owned small business, for moxifloxacin hydrochloride with a ceiling value of $7,489.44 on March 5, 2026. Performance occurs at the awardee's Brenham, Texas location with an ultimate completion date of March 5, 2027. The order is firm fixed price with no set-aside designation.</p>
- <p>The Defense Logistics Agency's Medical Supply Chain issued a $17,457.69 delivery order to Amerisourcebergen Drug Corp on May 19, 2025, for moxifloxacin HCL 400 mg tablets (unit dose, 50s).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of May 20, 2025. No set-aside was used.</p>
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. The contract, valued at $2,001.00, is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award was made through open competition without set-aside designation, and performance will be executed from AmerisourceBergen's facility in...
- <p>The Defense Logistics Agency issued a $2,924.46 delivery order to Amerisourcebergen Drug Corp on May 8, 2026, for moxifloxacin HCl 400 mg tablets under a DLA pharmaceutical supply contract, with completion scheduled for May 11, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $1,859.13 delivery order to Amerisourcebergen Drug Corp on May 11, 2026, for moxifloxacin HCL 400 mg tablets.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of May 12, 2026. No set-aside was used.</p>
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count), valued at $1,168.21 under a firm fixed-price contract type. The award was not set-aside and represents a competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. Performance will be completed by August 26, 2025, with fulfillment from...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Moxifloxacin HCl 400 mg tablets in unit dose packages of 50 units. This contract, valued at $6,900, utilizes firm fixed pricing with an ultimate completion date of August 11, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- <p>The Defense Logistics Agency issued a $1,305.56 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for moxifloxacin HCL 400 mg tablets.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of May 5, 2026. No set-aside was used.</p>
- The Defense Logistics Agency issued a $2,538.05 delivery order to Amerisourcebergen Drug Corp on May 11, 2026, for moxifloxacin HCl 400 mg tablet UD 50s, with an ultimate completion date of May 12, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. This is a transactional pharmaceutical delivery order under Amerisourcebergen's standing relationship with DLA Troop Support Medical, reflecting the company's role as a leading pharmaceutical distributor...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The award is for the delivery of moxifloxacin, a pharmaceutical product, with a ceiling value of $1,086.29. The contract has an ultimate completion date of March 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value...
The Defense Logistics Agency's Medical Supply Chain awarded a purchase order to Core Trading Co for $2,995.00 on May 13, 2026, for Moxifloxacin Hydrochloride pharmaceutical products under firm fixed price with no set-aside. Core Trading Co is a service-disabled veteran-owned small business and self-certified small disadvantaged business. Performance is located in Chesapeake, Virginia. The order has an ultimate completion date of May 26, 2026.
Generated 8/11/26, 10:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 5/12/26 |